Skip to main content

Table 3 The combination index values of 10-HDA and ZnONPs, including kidney lead content, kidney function tests, and the markers of oxidative stress, inflammation, and apoptosis

From: Combination of 10-hydroxy-decanoic acid and ZnO nanoparticles abrogates lead acetate-induced nephrotoxicity in rats: targeting oxidative stress and inflammatory signalling

 

CI value

Effect

Tissue lead content (ppm)

0.44 ± 0.008

Synergism

Kidney function parameters

BUN (mg/dl)

0.43 ± 0.019

Synergism

Urea (mg/dl)

0.41 ± 0.020

Synergism

Creatinine (mg/dl)

0.37 ± 0.005

Synergism

Cystatin C (mg/l)

0.30 ± 0.04

Synergism

Oxidative stress indices

MDA (mM/mg protein)

0.52 ± 0.086

Synergism

GSH (mM/mg protein)

0.63 ± 0.022

Synergism

GST (U/mg protein)

0.72 ± 0.015

Synergism

SOD (U/mg protein)

0.56 ± 0.022

Synergism

Nrf2 (relative band intensity)

0.564 ± 0.025

Synergism

HO-1 (relative band intensity)

0.55 ± 0.006

Synergism

Inflammatory mediators

TNF-α (Fold change)

0.10 ± 0.002

Synergism

IL-1β (Fold change)

0.33 ± 0.023

Synergism

IL-6 (Fold change)

0.37 ± 0.022

Synergism

IL-8 (Fold change)

0.45 ± 0.046

Synergism

p-IKK (relative band intesity)

0.492 ± 0.031

Synergism

NO (mM/mg protein)

0.53 ± 0.019

Synergism

Apoptotic markers

Bcl-2 (Fold change)

0.60 ± 0.014

Synergistic

Caspase − 3 (Fold change)

0.33 ± 0.03

Synergistic

Bax (Fold change)

0.47 ± 0.03

Synergistic

  1. A CI value of < 1 indicates a synergistic effect, > 1 indicates an antagonistic effect, and = 1 indicates an additive effect. The values are expressed as means ± SD.